🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound

Journal of Virology(2022)10.1128/jvi.00636-22Source: DataRank Database

Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound is a research paper published in Journal of Virology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (29 grants)Impact (FWCI 1.02)OA: hybridTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Jonathan Richard ORCID,Catherine Bourassa ORCID,Guillaume Goyette ORCID,Ta-Jung Chiu ORCID,Hung-Ching Chen ORCID

Live enrichment

PubMed:35980207 PMC:PMC9472635 OpenAlex:https://openalex.org/W4293826739

HHS | National Institutes of Health

Grant: AI145547

HHS | National Institutes of Health

Grant: AI124982

HHS | National Institutes of Health

Grant: AI129017

HHS | National Institutes of Health

Grant: AI164562

HHS | National Institutes of Health

Grant: AI150471

HHS | National Institutes of Health

Grant: AI148379

HHS | National Institutes of Health

Grant: AI150322

HHS | National Institutes of Health

Grant: AI129769

Gilead Sciences

Grant: 02010

Gouvernement du Canada | Canadian Institutes of Health Research

Grant: 352417

Gouvernement du Canada | Canadian Institutes of Health Research

Grant: 422148

Canada Foundation for Innovation

Grant: 41027

Canada Research Chairs

Grant: RCHS0235 950-232424

NIAID NIH HHS

Grant: P01 AI150471

NIAID NIH HHS

Grant: UM1 AI164562

NIAID NIH HHS

Grant: R33 AI129017

NIAID NIH HHS

Grant: R01 AI145547

NIAID NIH HHS

Grant: R01 AI148379

NIAID NIH HHS

Grant: R21 AI129017

NIAID NIH HHS

Grant: R01 AI129769

NIAID NIH HHS

Grant: R01 AI150322

NIAID NIH HHS

Grant: R01 AI124982

National Institutes of Health

Grant: 5UM1AI164562-03

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)

National Institutes of Health

Grant: 1R01AI150322-01

Characterizing HIV-1 Env conformations susceptible to attack by non-neutralizing antibodies

National Institutes of Health

Grant: 5R01AI148379-02

Assessing ADCC and Fc-mediated Protection against HIV

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5P01AI150471-26

Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry

National Institutes of Health

Grant: 5R01AI124982-08

Conformational Landscape of the HIV-1 Envelope Glycoproteins

National Institutes of Health

Grant: 5R33AI129017-05

Reducing viral reservoirs by opening HIV-1 Env to antibody attack

FWCI

1.02

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1128/jvi.00636-22

publisherhttps://doi.org/10.1128/jvi.00636-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.00636-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35980207

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9472635

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentHerpesvirus Infections and Treatments0301 basic medicine03 medical and health sciences

MeSH Terms

Binding SitesGlycoproteinsGuanidinesHumansIndenesMutationProtein ConformationHIV-1HIV InfectionsHIV Envelope Protein gp120HIV Envelope Protein gp41CD4 AntigensReceptors, HIVHIV Fusion InhibitorsDrug Resistance, Viralenv Gene Products, Human Immunodeficiency Virus

Keywords

Gp41BiologyGlycoproteinConformational changeViral envelopeVirusViral entryVirologyPlasma protein bindingViral replicationTrimerEntry inhibitorBinding siteMolecular biologyBiochemistryAntibodyChemistryGeneticsEpitopeResistanceHuman immunodeficiency virusCD4EnvelopeBnm-iii-170Cd4-mimetic CompoundBinding SitesProtein Conformationenv Gene Products, Human Immunodeficiency VirusHIV InfectionsHIV Envelope Protein gp120GuanidinesHIV Envelope Protein gp41Receptors, HIVIndenesHIV Fusion InhibitorsCD4 AntigensDrug Resistance, ViralMutationHIV-1HumansGlycoproteins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (10)

Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions

N/A

0.425DataRank · unranked

Journal of Virology(2020)

co-citedsame journal

10.1128/jvi.01968-19

ColabFold: making protein folding accessible to all

N/A

1.4DataRank · unranked

Nature Methods(2022)

co-cited

10.1038/s41592-022-01488-1

NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data

N/A

1.2DataRank · unranked

Nucleic Acids Research(2020)

co-cited

10.1093/nar/gkaa379

A Global Ramachandran Score Identifies Protein Structures with Unlikely Stereochemistry

Structure(2020)

co-cited

10.1016/j.str.2020.08.005

Protein aggregation and immunogenicity of biotherapeutics

N/A

0.774DataRank · unranked

International Journal of Pharmaceutics(2020)

co-cited

10.1016/j.ijpharm.2020.119523

The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?

N/A

0.542DataRank · unranked

Frontiers in Immunology(2020)

co-cited

10.3389/fimmu.2020.01223

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

N/A

0.889DataRank · unranked

Nature Medicine(2021)

co-cited

10.1038/s41591-021-01590-5

Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies

Immunity(2021)

co-cited

10.1016/j.immuni.2021.10.017

Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review

Journal of the International AIDS Society(2021)

co-cited

10.1002/jia2.25797

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Frontiers in Immunology(2022)

co-cited

10.3389/fimmu.2022.812774